Open AccessSorafenib after resection improves the outcome of BCLC stage C hepatocellular carcinoma
Author(s) -
Li Jiang,
Yu Hou,
Xiao-Bei Cai,
Bin Liu
Publication year - 2016
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v22.i15.4034
Subject(s) - medicine , hepatocellular carcinoma , sorafenib , liver function , metastasis , liver cancer , gastroenterology , surgery , cancer
To evaluate whether sorafenib use after resection impacts tumor relapse and survival in Barcelona Clinic Liver Cancer (BCLC) stage C hepatocellular carcinoma (HCC).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom